Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ignyta's cancer drug entrectinib receives FDA orphan drug status

pharmaceutical-technologyJuly 12, 2017

Tag: cancer drug , Ignyta , Orphan Drug

PharmaSources Customer Service